We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...

Philanthropy has played a key role in the progress we have made over the years and there are many opportunities to play a part in the future of cancer research. We are proud of the relationships we ...

Perspectives in Oncology provides staff and students with a common grounding in basic cancer science, and includes modules in cancer epidemiology, cancer genetics, cell biology, bioinformatics, ...

The Cancer Epidemiology and Prevention Research Unit (CEPRU) is a joint initiative between The Institute of Cancer Research, ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

We played a major role in characterising the BRAF gene and its role in cancer, increasing our understanding of malignant melanoma. Our work on the gene and the structure of the BRAF protein ...

Our academic clinicians bring knowledge of clinical practice into the lab and take laboratory research back into the clinic ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...